.Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L03A_Immunostimulants.L03AB08_InterferonBeta1b.InterferonBeta1b .Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L03A_Immunostimulants.L03AB08_InterferonBeta1b.InterferonBeta1b| name: | InterferonBeta1b |
| ATC code: | L03AB08 | route: | subcutaneous |
| n-compartments | 2 |
Interferon beta-1b is a recombinant form of human interferon beta used as an immunomodulatory agent in the treatment of relapsing forms of multiple sclerosis (MS). It functions by modifying the immune response and reducing inflammation. Interferon beta-1b is an FDA- and EMA-approved medication that has been in clinical use for MS for several decades.
Pharmacokinetic parameters following subcutaneous administration of 250 micrograms in healthy adult volunteers.
Connelly, JF (1994). Interferon beta for multiple sclerosis. The Annals of pharmacotherapy 28(5) 610–616. DOI:10.1177/106002809402800511 PUBMED:https://pubmed.ncbi.nlm.nih.gov/8069001
Johnston, J, & So, TY (2012). First-line disease-modifying therapies in paediatric multiple sclerosis: a comprehensive overview. Drugs 72(9) 1195–1211. DOI:10.2165/11634010-000000000-00000 PUBMED:https://pubmed.ncbi.nlm.nih.gov/22642799